Insider holders · CIK 0001849296
OKYO Pharma Ltd · OKYO
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Gabriele M CerroneDirector | — | 10,873,916 | 10,873,916 | Aug 7, 2026 · 4:15 pm EDT | Form 4/A |
| Gary S JacobCHIEF DEVELOPMENT OFFICER | 112,420 | — | 112,420 | Aug 7, 2026 · 4:15 pm EDT | Form 4/A |
| John P BrancaccioDirector | 35,201 | — | 35,201 | Aug 7, 2026 · 4:15 pm EDT | Form 4/A |
| Rajkumar V. PatilChief Scientific Officer | 20,030 | — | 20,030 | Aug 7, 2026 · 4:15 pm EDT | Form 4/A |
| Flavio MantelliCHIEF MEDICAL OFFICER | 20,000 | — | 20,000 | Aug 7, 2026 · 4:15 pm EDT | Form 4/A |
| Robert John DempseyCHIEF EXECUTIVE OFFICER | 15,000 | — | 15,000 | Aug 7, 2026 · 4:15 pm EDT | Form 4/A |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.